Organisation is kicking off a flagship initiative as it views mental health as a key public health concern in the WHO European region, where more than 110 million people are living with some type of mental health issue.
The World Health Organisation (WHO) announced a new flagship initiative, “a mental health coalition to support system reforms and COVID-19 recovery” in Europe.
This was undertaken because of the organisation’s recognition that “mental health is a key public health concern in the WHO European Region – more than 110 million people are living with some kind of mental health condition, accounting for over 10% of the population.”
“The mental health flagship will bring together a broad coalition of mental health leaders, champions, service users and other partners to improve mental health policies and practices across the region,” the WHO said in a statement.
Considering the COVID-19 virus, focusing on mental health now is especially important given that the measures to prevent the virus from spreading, such as social distancing and quarantining, in addition to the dangerous working conditions for health care workers, are having a psychological impact on the population and exacerbate pre-existing anxiety.
The WHO explained that the Mental Health Initiative will challenge “stigma and discrimination by improving mental health awareness and literacy among not only the public but also service providers and decision makers.”
In addition, it will enhance access to “person-centered, rights-based mental health care in communities. This will expedite progress towards universal health coverage for people with mental health conditions and make the case for a parity of esteem between mental and physical health.”
The Mental Health initiative is one of 4 launched by the WHO. The other 3 priorities for WHO/Europe over the next 5 years are digital health and innovation, behavioural and cultural insights, and immunization.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.